Professor Schadendorf is Director of the Clinic for Dermatology and the West German Cancer Center (WTZ) at the University Hospital Essen. He attended the Medical Faculty of the University Hospital Hamburg and has been a licensed physician since 1986. Professor Schadendorf was president of the German Dermatologic Cooperative Oncology Group (DeCOG) from 2010 to 2018. He has served in various capacities on the steering committee of the well-known EORTC Melanoma Group for more than 2 decades. He is currently involved in more than 30 clinical trials. He has a strong focus on translational research with particular interest in tumor immunology, therapy resistance, tumor heterogeneity, and plasticity and target therapy. Prof. Schadendorf has published more than 700 peer-reviewed journal articles (see PubMed) covering many aspects of clinical and translational skin cancer research.